Association of Inflammatory Markers with Cardiovascular Risk and Sleepiness
University of Warwick, Warwick Medical School, Division of Metabolic and Vascular Health, Coventry, UK
There is emerging evidence suggesting that disturbances in sleep and sleep disorders play a role in the morbidity of chronic conditions including obesity and hypertension as well as in the development of type-2 diabetes. This brief review examines the role of inflammation in the development of atherosclerosis. Furthermore, it outlines the utility of inflammatory markers and, in particular, adhesion molecules as biomarkers for cardiovascular risk and the factors that affect their level in the circulation. It then discusses the relationship between sleep and markers of inflammation and the role of sleep in immune function.
Miller MA. Association of inflammatory markers with cardiovascular risk and sleepiness. J Clin Sleep Med 2011;7(5):Supplement S31-S33.
Please login to continue reading the full article
Subscribers to JCSM get full access to current and past issues of the JCSM.
Login to JCSM
Not a subscriber?
Join the American Academy of Sleep Medicine and receive a subscription to JCSM with your membership